Search
frovatriptan (Frova)
Tradename: Frova. Scheduled for release in 2002.
Indications: migraine headache
Dosage:
1) 2.5 mg; may repeat after 2 hours
2) maximum: 7.5 mg QD
Tabs: 2.5 mg
Pharmacokinetics:
1) slow onset of action, long duration
2) elimination 1/2 life of 26 hours
Mechanism of action:
-> serotonin receptor agonist
Notes: Manufacturer: Elan
Interactions
drug interactions
drug adverse effects of triptan(s)
General
amine
heterocyclic compound, 2 rings
serotonin agonist (5-HT receptor agonist, triptan)
Database Correlations
PUBCHEM correlations
References
- Prescriber's Letter 8(12):68 2001
- Prescriber's Letter 9(1):1 2002